High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$18.8M
$18,767,121
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
PTGX
S
Protagonist Therapeutics, Inc
Williams Lewis T
• Director
Discretionary SellΔOwn -69.7%
2026-02-17
$1,483,560Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Director
Discretionary SellΔOwn -69.7%
|
2026-02-17 | $1,483,560Large | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
Waddill William D.
• Director
Discretionary SellΔOwn -71.9%
2026-02-06
$1,673,600Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Director
Discretionary SellΔOwn -71.9%
|
2026-02-06 | $1,673,600Large | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CFO
Discretionary SellΔOwn -23.2%
|
2026-01-27 | $3,841,037Largex2 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
MOLINA ARTURO MD
• Officer • Chief Medical Officer
Discretionary Sell
2026-01-27
$410,000
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Officer • Chief Medical Officer
Discretionary Sell
|
2026-01-27 | $410,000 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-01-27
$338,417
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-01-27 | $338,417 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
MOLINA ARTURO MD
• Officer • Chief Medical Officer
Discretionary Sell
2026-01-26
$411,400
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Officer • Chief Medical Officer
Discretionary Sell
|
2026-01-26 | $411,400 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-01-26
$2,091,470Largex2
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-01-26 | $2,091,470Largex2 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
MOLINA ARTURO MD
• Officer • Chief Medical Officer
Discretionary SellΔOwn -13.5%
2026-01-23
$1,083,905Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Officer • Chief Medical Officer
Discretionary SellΔOwn -13.5%
|
2026-01-23 | $1,083,905Large | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-01-23
$1,633,856Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-01-23 | $1,633,856Large | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CFO
Sell to Cover
|
2026-01-20 | $708,338 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
MOLINA ARTURO MD
• Officer • Chief Medical Officer
Sell to Cover
2026-01-20
$784,715
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-01-20 | $784,715 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Sell to Cover
2026-01-20
$2,840,446Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Sell to Cover
|
2026-01-20 | $2,840,446Large | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
MOLINA ARTURO MD
• Officer • Chief Medical Officer
Sell to Cover
2025-11-17
$229,896
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-11-17 | $229,896 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
Waddill William D.
• Director
10b5-1 SellΔOwn -23.4%
2025-10-10
$979,480x2
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Director
10b5-1 SellΔOwn -23.4%
|
2025-10-10 | $979,480x2 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
Waddill William D.
• Director
10b5-1 SellΔOwn -43.8%
2025-09-22
$257,000
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Director
10b5-1 SellΔOwn -43.8%
|
2025-09-22 | $257,000 | S | Form 4 |